State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha 410082, P. R. China.
Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Institute of Engineering Medicine, Beijing Institute of Technology, Beijing 100081, P. R. China.
Langmuir. 2023 Feb 14;39(6):2192-2203. doi: 10.1021/acs.langmuir.2c02675. Epub 2023 Feb 3.
A β-amyloid (Aβ) aggregation process is a spontaneous process where the original random coil or helical structure changes into a regularly arranged β-sheet structure. The development of inhibitors with the features of low cost, high efficiency, and biosafety by targeting Aβ self-aggregation is significant for Alzheimer's disease treatment. However, the issues of low inhibition efficiency under low concentrations of inhibitors and biological toxicity are currently to be addressed. To resolve the above problems, a DNA nanoassembly (HCR-Apt) based on spatially ordered recognition elements was constructed by targeted disruption of Aβ ordered arrangement. It was discovered that HCR-Apt could inhibit effectively the fibrillation of Aβ monomers and oligomers at substoichiometric ratios. This may be due to orderly arrangement of aptamers in rigid nanoskeletons for enhancing the recognition interaction between aptamers and Aβ. The strong interaction between HCR-Apt and Aβ limited the flexible conformational conversion of Aβ molecules, thereby inhibiting their self-assembly. Computational simulations and experimental analysis revealed the interactions of Apt with Aβ, which explained different inhibition effects on the fibrillation of Aβ monomers and oligomers. Furthermore, the analysis of tyrosine intrinsic fluorescence spectra and surface plasmon resonance imaging showed that the interaction of HCR-Apt and Aβ was stronger than that of Apt and Aβ. These findings contributed to establishing a promising method of boosting the recognition interaction by orderly arrangement of recognition elements. Taken together, this work is expected to provide a simple and efficient strategy for inhibiting Aβ aggregation, expanding aptamer's application potential in neurodegenerative diseases.
β-淀粉样蛋白(Aβ)聚集过程是一个自发过程,其中原始的无规卷曲或螺旋结构转变为规则排列的β-折叠结构。通过靶向 Aβ 自聚集,开发具有低成本、高效率和生物安全性特征的抑制剂对于治疗阿尔茨海默病具有重要意义。然而,目前仍需要解决抑制剂在低浓度下抑制效率低和生物毒性的问题。为了解决上述问题,通过靶向破坏 Aβ 的有序排列,构建了一种基于空间有序识别元件的 DNA 纳米组装体(HCR-Apt)。研究发现,HCR-Apt 可以在亚化学计量比下有效抑制 Aβ 单体和低聚物的纤维化。这可能是由于适体在刚性纳米骨架中的有序排列增强了适体与 Aβ 之间的识别相互作用。HCR-Apt 与 Aβ 之间的强相互作用限制了 Aβ 分子的柔性构象转换,从而抑制了它们的自组装。计算模拟和实验分析揭示了 Apt 与 Aβ 的相互作用,解释了 Apt 对 Aβ 单体和低聚物纤维化的不同抑制效果。此外,酪氨酸本征荧光光谱和表面等离子体共振成像分析表明,HCR-Apt 与 Aβ 的相互作用强于 Apt 与 Aβ 的相互作用。这些发现有助于建立一种通过有序排列识别元件来增强识别相互作用的有前途的方法。总之,这项工作有望为抑制 Aβ 聚集提供一种简单有效的策略,扩展适体在神经退行性疾病中的应用潜力。